SET Announcements
12 November 2021
Management Discussion and Analysis Quarter 3 Ending 30 Sep 2021
Read More
12 November 2021
Financial Performance Quarter 3 (F45) (Reviewed)
Read More
12 November 2021
Financial Statement Quarter 3/2021 (Reviewed)
Read More
20 September 2021
Clarification of Big Lot transaction
Read More
16 August 2021
Resolution of Board meetings No. 4/2021, appointment of sub-committees (amended)
Read More
13 August 2021
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2021
Read More
13 August 2021
Financial Performance Quarter 2 (F45) (Reviewed)
Read More
13 August 2021
Financial Statement Quarter 2/2021 (Reviewed)
Read More
13 August 2021
Resolution of Board meetings No. 4/2021, appointment of sub-committees
Read More
15 July 2021
Report of Utilization the Capital Increase from IPO (No. 4) ended on June 30, 2021
Read More
13 July 2021
The Company and its Subsidiary has been additional approved of Narcotics Substance Category 5, Hemp Only
Read More
02 July 2021
Approval of Narcotics Substance Category 5, Hemp Only
Read More